JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
STEX
Streamex Corp.
There isn't enough reported data to score STEX yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
STEX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
STEX's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like STEX.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
STEX PE Valuation
STEX has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.3x next year's earnings.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
STEX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect STEX to return to profit, with revenue growing.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus STEX down 223%.
STEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.05 | — |
| Q3 2022 | -$7.13 | +$3.07 |
| Q2 2022 | -$7.90 | +$4.00 |
| Q1 2022 | -$8.99 | +$7.71 |
| Q4 2021 | -$9.58 | +$9.12 |
| Q3 2021 | -$10.20 | +$12.30 |
| Q2 2021 | -$11.90 | +$9.30 |
| Q1 2021 | -$16.70 | +$1.10 |
| Q4 2020 | -$18.70 | -$2.20 |
STEX is still losing money, but far less than before: $8.74 per share over the past year, against $22.50 at its worst in late 2020.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
STEX has the stronger quarterly revenue trend. Revenue is up 8.1% for JPM versus up 1,015% for STEX.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over STEX on profitability, with a higher operating margin.
STEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $13K | +8.3% |
| Q1 2024 | $14K | +180% |
| Q4 2023 | $12K | -91% |
| Q3 2023 | $1K | -99% |
| Q1 2023 | $5K | -38% |
| Q4 2022 | $135K | +1588% |
| Q3 2022 | $135K | +25% |
| Q2 2022 | $8K | -96% |
STEX's revenue is recovering but still below its 2021 peak: $145,000 last quarter, up 1015% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12397% | N/A |
| Q2 2026 | -10384% | N/A |
| Q4 2024 | -9100% | +42292 points |
| Q2 2024 | -40708% | N/A |
| Q1 2024 | -24550% | +123170 points |
| Q4 2023 | -51392% | -46208 points |
| Q3 2023 | -405100% | -400296 points |
| Q1 2023 | -147720% | -46908 points |
STEX's operating margin was −12397% last quarter, up 12153 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
STEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.1M | -$1.1M |
| Q2 2026 | -$11.7M | -$10.5M |
| Q1 2026 | -$10.2M | -$9.1M |
| Q4 2023 | -$2.9M | +$1.2M |
| Q3 2023 | -$3.9M | +$1.1M |
| Q2 2023 | -$5M | +$1.7M |
| Q1 2023 | -$5.7M | +$303K |
| Q4 2022 | -$4.2M | +$1.7M |
STEX has the edge over JPM on cash flow, with more consistent year-over-year improvement.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over STEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
STEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +3.3M shares |
| 1 year | +569% | +158M shares |
| 3 years | +2672% | +179M shares |
| 5 years | +6542% | +183M shares |
STEX has 185M diluted shares, up 569% from a year ago.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
STEX Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
STEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 2.9 | Oversold |
STEX's weekly RSI is 34 (neutral) and its Stochastic is 3 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
STEX PE vs Financial Services Sector
STEX has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has stronger trend alignment. JPM is above 4 of 5 weekly averages versus STEX above 0 of 3.
STEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.46 | 33% below |
| 20 week MA | $0.66 | 53% below |
| 50 week MA | $1.52 | 80% below |
STEX is in a downtrend: it's below all three of its weekly moving averages, and 80% below its 50-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over STEX on returns for 2026, with the stronger performance.
STEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $6.27 | $3.14 | -50% |
| 2026 YTD | $3.14 | $0.31 | -90% |
STEX has finished every year since 2025 lower, and it's down 90% so far in 2026.